Marijuana Company of America Inc. (MCOA) Creates Moat around Flagship CBD Product with US Patent
- Marijuana Company of America receives patent for hempSMART Brain
Warren Buffett, ‘the Oracle of Omaha’, famously said, “A truly great business must have an enduring ‘moat’ that protects excellent returns on invested capital.” By a moat, the legendary investor meant some competitive advantage that would sustain the enterprise by protecting its market from rival firms. A patent, like the one issued to Marijuana Company of America Inc. (OTCQB: MCOA), can work just as well, he said (http://nnw.fm/8ZzVK).
A patent stops others from counterfeiting products or manufacturing replicas and knockoffs. It is particularly essential when the stakes are high, as they are in the U.S. hemp-based product market, which is forecast to approach $2 billion in three years. So the recent award of a U.S. patent puts MCOA in a decidedly stronger market position. The U.S. Patent and Trademark Office has granted MCOA a patent for the formulation of its flagship CBD product, hempSMART Brain, a wellness product formulated with a proprietary composition of natural ingredients and cannabidiol (CBD) for the enhancement of brain function (http://nnw.fm/alGS0).
MCOA’s hempSMART Brain is a unique product in that it utilizes a synergistic blend of natural neuroprotective and neuro-regenerative compounds, including CBD, in clinically researched and verified therapeutic amounts. Clinical studies indicate that CBD facilitates brain recovery by aiding in normal cell production. The human brain is “fitted” with natural specialized receptors for CBD, part of the endocannabinoid system that maintains homeostasis, or a stable internal environment in the body, as the external environment changes. Spurred by changes in the legislative environment, research into the use of cannabinoids to supplement neurologic and neurodegenerative concerns has been increasing, with encouraging results.
MCOA is an industrial hemp company that conducts and participates in product research and the development of legal hemp-based consumer products under the brand name ‘hempSMART’. The company distributes and sells its products through an affiliate marketing program. It intends to continue expanding its footprint in ancillary areas of the legalized cannabis and hemp industry.
For more information, visit the company’s website at www.MarijuanaCompanyofAmerica.com
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
- Marijuana Company of America receives patent for hempSMART Brain
Warren Buffett, ‘the Oracle of Omaha’, famously said, “A truly great business must have an enduring ‘moat’ that protects excellent returns on invested capital.” By a moat, the legendary investor meant some competitive advantage that would sustain the enterprise by protecting its market from rival firms. A patent, like the one issued to Marijuana Company of America Inc. (OTCQB: MCOA), can work just as well, he said (http://nnw.fm/8ZzVK).
A patent stops others from counterfeiting products or manufacturing replicas and knockoffs. It is particularly essential when the stakes are high, as they are in the U.S. hemp-based product market, which is forecast to approach $2 billion in three years. So the recent award of a U.S. patent puts MCOA in a decidedly stronger market position. The U.S. Patent and Trademark Office has granted MCOA a patent for the formulation of its flagship CBD product, hempSMART Brain, a wellness product formulated with a proprietary composition of natural ingredients and cannabidiol (CBD) for the enhancement of brain function (http://nnw.fm/alGS0).
MCOA’s hempSMART Brain is a unique product in that it utilizes a synergistic blend of natural neuroprotective and neuro-regenerative compounds, including CBD, in clinically researched and verified therapeutic amounts. Clinical studies indicate that CBD facilitates brain recovery by aiding in normal cell production. The human brain is “fitted” with natural specialized receptors for CBD, part of the endocannabinoid system that maintains homeostasis, or a stable internal environment in the body, as the external environment changes. Spurred by changes in the legislative environment, research into the use of cannabinoids to supplement neurologic and neurodegenerative concerns has been increasing, with encouraging results.
MCOA is an industrial hemp company that conducts and participates in product research and the development of legal hemp-based consumer products under the brand name ‘hempSMART’. The company distributes and sells its products through an affiliate marketing program. It intends to continue expanding its footprint in ancillary areas of the legalized cannabis and hemp industry.
For more information, visit the company’s website at www.MarijuanaCompanyofAmerica.com
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
